MORRIS PLAINS, N.J., June 14, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at the 2012 Wells Fargo Securities Healthcare Conference on Wednesday, June 20, 2012 at 8:30 am Eastern Time at The InterContinental Hotel in Boston, MA. The presentation, which will provide a corporate overview, can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf, will provide a corporate overview.
